Us Bancorp \De\ Madrigal Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 563 shares of MDGL stock, worth $122,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares

563

Previous 792 28.91%

Holding current value

$122,171

Previous $221,000 46.15%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$212.22 - $292.96 $48,598 - $67,087	-229 Reduced 28.91%	563 $119,000
Q2 2024 Aug 06, 2024	BUY	$193.33 - $291.99 $11,213 - $16,935	58 Added 7.9%	792 $221,000
Q1 2024 May 07, 2024	SELL	$171.37 - $283.23 $112,932 - $186,648	-659 Reduced 47.31%	734 $196,000
Q4 2023 Feb 09, 2024	SELL	$120.4 - $237.13 $102,821 - $202,509	-854 Reduced 38.01%	1,393 $322,000
Q3 2023 Nov 03, 2023	SELL	$146.04 - $225.78 $24,388 - $37,705	-167 Reduced 6.92%	2,247 $328,000
Q2 2023 Aug 09, 2023	BUY	$203.88 - $312.0 $100,512 - $153,816	493 Added 25.66%	2,414 $557,000
Q1 2023 May 09, 2023	BUY	$231.06 - $307.08 $328,336 - $436,360	1,421 Added 284.2%	1,921 $465,000
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $8,291 - $42,108	142 Added 39.66%	500 $145,000
Q3 2022 Oct 27, 2022	BUY	$60.57 - $79.51 $12,235 - $16,061	202 Added 129.49%	358 $23,000
Q2 2022 Aug 01, 2022	SELL	$58.04 - $100.2 $11,259 - $19,438	-194 Reduced 55.43%	156 $11,000
Q1 2022 May 11, 2022	BUY	$55.89 - $101.89 $2,067 - $3,769	37 Added 11.82%	350 $34,000
Q4 2021 Feb 11, 2022	BUY	$72.34 - $95.09 $20,761 - $27,290	287 Added 1103.85%	313 $27,000
Q3 2021 Nov 10, 2021	SELL	$78.35 - $105.02 $6,189 - $8,296	-79 Reduced 75.24%	26 $2,000
Q2 2021 Aug 05, 2021	SELL	$97.2 - $137.59 $777 - $1,100	-8 Reduced 7.08%	105 $10,000
Q1 2021 Apr 28, 2021	BUY	$108.54 - $125.2 $8,574 - $9,890	79 Added 232.35%	113 $13,000
Q4 2020 Feb 04, 2021	BUY	$110.06 - $133.7 $2,861 - $3,476	26 Added 325.0%	34 $4,000
Q2 2020 Aug 07, 2020	SELL	$60.13 - $125.71 $13,709 - $28,661	-228 Reduced 96.61%	8 $1,000
Q1 2020 May 13, 2020	BUY	$66.76 - $93.49 $534 - $747	8 Added 3.51%	236 $16,000
Q4 2019 Feb 04, 2020	SELL	$84.28 - $118.5 $2,612 - $3,673	-31 Reduced 11.97%	228 $21,000
Q3 2019 Nov 08, 2019	BUY	$84.4 - $106.53 $19,243 - $24,288	228 Added 735.48%	259 $22,000
Q4 2018 Feb 13, 2019	SELL	$94.77 - $215.54 $6,349 - $14,441	-67 Reduced 68.37%	31 $3,000
Q3 2018 Nov 01, 2018	BUY	$207.3 - $300.31 $9,743 - $14,114	47 Added 92.16%	98 $21,000
Q2 2018 Aug 08, 2018	BUY	$101.55 - $313.9 $5,179 - $16,008	51 New	51 $14,000

Others Institutions Holding MDGL

# of Institutions

297

Shares Held

21.9M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.71B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account